Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies-Reference-Cited by-同舟云学术

Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies

Published:2020-02 Issue:6 Volume:75 Page:620-628
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Bonsu Janice M.,Guha Avirup,Charles Lawrence,Yildiz Vedat O.,Wei Lai,Baker Brandee,Brammer Jonathan E.,Awan Farrukh,Lustberg Maryam,Reinbolt Raquel,Miller Eric D.,Jneid Hani,Ruz Patrick,Carter Rebecca R.,Milks Michael W.,Paskett Electra D.,Addison Daniel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

3. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

4. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer;Schmid;N Engl J Med,2018

5. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors;Raymond;N Engl J Med,2011

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Representation of women in clinical trials supporting FDA‐approval of contemporary cancer therapies;International Journal of Cancer;2024-08-19

2. Cardiovascular risk in cancer patients treated with immune checkpoint inhibitors: challenges and future directions;European Journal of Preventive Cardiology;2024-06-13

3. Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials;JACC: CardioOncology;2024-04

4. Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA);American Heart Journal Plus: Cardiology Research and Practice;2024-04

5. Perspectives on the Cardiovascular and Metabolic Effects of Androgen Deprivation Therapy in Prostate Cancer;Current Oncology Reports;2024-02-20